Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curosurf for BPD Prevention in Very Preterm Neonates
NCT01039285Phase 4Completed
- Start
- Dec 2009
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Poractant alfa in bronchopulmonary dysplasia (BPD). Started Dec 2009; status: completed.
02
Drugs
Poractant alfa
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01039285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039285.